Part 8/13:
The device, tested on 36 patients, includes implanted brain sensors, a robotic glove, surgical tools, and software that interprets neural signals to improve hand grasping abilities. While less advanced than some experimental implants capable of enabling paralyzed individuals to browse the internet or engage in complex activities, this approval marks a critical regulatory milestone aligning with China's five-year plan, which identifies BCI as a "future industry" requiring supportive regulation and reimbursement policies.
Investor enthusiasm is palpable, with Hong Kong-listed companies and global players like Alibaba investing heavily to expand clinical trials and neural implant development, signaling China’s rapid advancement in neurotechnology.